UnitedHealth (UNH) director Charles D. Baker granted 343 deferred stock units

Rhea-AI Filing Summary

Baker Charles D. reported acquisition or exercise transactions in this Form 4 filing.

UNITEDHEALTH GROUP INC director Charles D. Baker received 343 deferred stock units of Common Stock as part of his regular quarterly board compensation. The units are immediately vested but must be held until he completes his service on the Board, bringing his direct holdings to 2,163 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Baker Charles D.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	343	$0.00	--

Holdings After Transaction: Common Stock — 2,163 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Deferred stock units granted: 343 units Holdings after transaction: 2,163 shares Price per share for award: $0.0000

3 metrics

Deferred stock units granted 343 units Regular quarterly compensation grant on 2026-04-01

Holdings after transaction 2,163 shares Common Stock directly owned following the award

Price per share for award $0.0000 Reported transaction price per share for the grant

Key Terms

deferred stock units, regular quarterly compensation, immediately vested, retained by the director until the director's completion of service

4 terms

deferred stock units financial

"Represents deferred stock units that are granted as regular quarterly compensation"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

regular quarterly compensation financial

"granted as regular quarterly compensation for service as a director"

immediately vested financial

"Deferred stock units are immediately vested, but must be retained"

retained by the director until the director's completion of service financial

"must be retained by the director until the director's completion of service on the Board"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Baker Charles D.

(Last) (First) (Middle)

C/O UNITEDHEALTH GROUP INCORPORATED

1 HEALTH DRIVE

(Street)

EDEN PRAIRIE MINNESOTA 55344

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		A		343(1)	A	$0	2,163	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board.

Remarks:

	Faraz A. Choudhry, Attorney-in-Fact for Charles D. Baker	04/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Charles D. Baker report at UNH?

Charles D. Baker reported receiving 343 deferred stock units of UNITEDHEALTH GROUP INC Common Stock as regular quarterly director compensation. These units are part of routine board pay, not an open-market stock purchase or sale.

Is the UNH Form 4 transaction a buy or a grant for Charles D. Baker?

The Form 4 shows a grant/award acquisition, not an open-market buy. Baker received 343 deferred stock units as quarterly compensation for board service, with no price paid per share reported in the filing.

How many UNITEDHEALTH GROUP INC shares does Charles D. Baker hold after this award?

After receiving 343 deferred stock units, Charles D. Baker holds 2,163 shares of UNITEDHEALTH GROUP INC Common Stock directly. This figure reflects his position immediately following the reported compensation transaction.

What are deferred stock units in the UNH director compensation context?

For UNITEDHEALTH GROUP INC directors, deferred stock units are stock-based awards granted as regular quarterly compensation. They vest immediately but must be retained until the director finishes serving on the Board, aligning director interests with long-term shareholders.

Are Charles D. Baker’s deferred stock units at UNH immediately vested?

Yes. The filing states the deferred stock units are immediately vested when granted. However, Baker must retain these units until he completes his service on the UNITEDHEALTH GROUP INC Board, limiting near-term liquidity from this award.